Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) EPS (Basic) (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of EPS (Basic) readings, the most recent being $0.85 for Q1 2026.

  • On a quarterly basis, EPS (Basic) fell 30.89% to $0.85 in Q1 2026 year-over-year; TTM through Mar 2026 was $4.18, a 12.55% decrease, with the full-year FY2025 number at $4.56, up 4.35% from a year prior.
  • EPS (Basic) hit $0.85 in Q1 2026 for GE HealthCare Technologies, down from $1.29 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $1.58 in Q4 2024 to a low of $0.42 in Q1 2023.
  • Median EPS (Basic) over the past 5 years was $0.98 (2025), compared with a mean of $1.0.
  • Biggest five-year swings in EPS (Basic): crashed 51.16% in 2023 and later surged 95.24% in 2024.
  • GE HealthCare Technologies' EPS (Basic) stood at $1.22 in 2022, then decreased by 27.87% to $0.88 in 2023, then surged by 79.55% to $1.58 in 2024, then fell by 18.35% to $1.29 in 2025, then crashed by 34.11% to $0.85 in 2026.
  • The last three reported values for EPS (Basic) were $0.85 (Q1 2026), $1.29 (Q4 2025), and $0.98 (Q3 2025) per Business Quant data.